Sources say the account will cover the whole of Southeast Asia and is thought to be part of a bigger push that will span Asia-Pacific.
The win followed a pitch against undisclosed agencies.
While Saatchi & Saacthi confirmed the news, the agency’s representative could not speak about the project specifically.
The win followed a pitch against undisclosed agencies.
While Saatchi & Saacthi confirmed the news, the agency’s representative could not speak about the project specifically.
The network's CEO for Singapore and Malaysia Dean Taylor said: “2009 has been a year for restructuring and retooling for us. Along with this win, Nippon Paint and numerous extra projects from existing clients, we have been steadily growing our business so we can invest in new hires during 2010”.
He added: “We want our talent concentrating on these areas. MSD has been a great supporter of this approach over the last few months and we look forward to creating work that is totally in tune with the digital modernization of Asian consumers and patients."
Earlier in the year Mead Johnson consolidated its global creative account with Saatchi & Saatchi.
The win comes after MSD and Schering-Plough merged their companies on 3 November. The combined company will be called Merck in the US and Canada, and MSD outside the United States. The timeline for integrating the two firms' operations will vary by market.
Following the merger, MSD is now a healthcare leader with a diversified portfolio of prescription medicines, vaccines and consumer health products, as well as animal health products.
The company is a leader in areas including cardiology, infectious diseases, diabetes, respiratory, vaccines, women's health, sun care and animal health, and is additionally looking to expand its offerings in areas such as neurology, oncology and dermatology.
